Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | +4.35% | -11.58% | -9.68% |
Apr. 22 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
Apr. 12 | Top Premarket Decliners | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- ADIL Stock
- Revisions Adial Pharmaceuticals, Inc.